US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avon

5.60

0.0000

Volume:- -

Turnover:- -

Market Cap:2.48B

PE:-48.65

High:5.60

Open:5.60

Low:5.60

Close:5.60

52wk High:5.92

52wk Low:1.59

Shares:443.53M

Float Shares:378.82M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1151

EPS(LYR):-0.0987

ROE:-1.62%

ROA:6.61%

PB:-2.75

PE(LYR):-56.76

Loading ...

Overview Company News Filings

SpaceX IPO Puts Aerospace Stocks In Focus With Hammond Power Solutions and RADA

Simply Wall St.

Avon Technologies (AVON) Gets a Buy from Peel Hunt

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Provincial Disciplinary Authorities Announce Investigation into Li Yafang

Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity

Avon Technologies: Analyst Maintains Buy Rating as New NATO Contract Strengthens Order Book and Medium-Term Revenue Visibility

Andrew Douglas Reiterates Buy on Avon Technologies, Keeps $2390 Price Target After New U.S. Army Helmet Orders

Avon Technologies Secures Over $40 Million in U.S. Army Helmet Orders

Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

Avon Technologies Executives Buy Shares Under All-Employee Incentive Plan

Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026

Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Avon Technologies Delivers Profits Surge In Latest Call

Avon Technologies Reports Strong First-Half Performance with EPS of 56 Cents

Avon Technologies: Buy Rating Reiterated on Strong 1H26 Performance and Outlook; $2,330 Price Target Unchanged

Avon Technologies Beats Profit Targets Early as Defence Demand Surges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/AVP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","market":"US","secType":"STK","nameCN":"Avon","latestPrice":5.6,"timestamp":1578085200000,"preClose":5.6,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":378820896,"shares":443525346,"eps":-0.115112,"marketStatus":"Delisted","change":0,"latestTime":"10-22 11:27:51 EDT","open":5.6,"high":5.6,"low":5.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.115112,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1792699200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-179866800000,"exchange":"NYSE","adjPreClose":5.6,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVP\",,,,,undefined,":{"symbol":"AVP","floatShares":378820896,"roa":"6.61%","roe":"-1.62%","lyrEps":-0.098664,"shares":443525346,"dividePrice":0,"high":5.6,"amplitude":0,"preClose":5.6,"low":5.6,"week52Low":1.59,"pbRate":"-2.75","week52High":5.92,"institutionHeld":0.685,"latestPrice":5.6,"eps":-0.115112,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.115112,"open":5.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-12-27","symbol":"AVP","amount":0.0160442,"name":"雅芳","payableDate":"2019-12-30","currency":"USD","type":"dividend","dateTimestamp":1577422800000},{"date":"2019-10-31","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":0.03,"defaultRemindTime":1572508800000,"name":null,"time":"Pre-MKt","dateTimestamp":1572494400000,"actualEps":null},{"date":"2019-08-01","symbol":"AVP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":0.04,"defaultRemindTime":1564646400000,"name":null,"time":"Pre-MKt","dateTimestamp":1564632000000,"actualEps":-0.03},{"market":"US","date":"2019-05-02","symbol":"AVP","fiscalQuarterEnding":"2019/03","expectedEps":-0.01,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1556769600000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2019-02-14","symbol":"AVP","fiscalQuarterEnding":"2018/12","expectedEps":0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1550120400000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVP\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":null,"value":0.0160442,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657685028","title":"SpaceX IPO Puts Aerospace Stocks In Focus With Hammond Power Solutions and RADA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657685028","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657685028?lang=en_us&edition=fundamental","pubTime":"2026-08-06 15:41","pubTimestamp":1786002106,"startTime":"0","endTime":"0","summary":"SpaceX’s record breaking US$2t IPO and heavy AI spending have just thrown a spotlight on aerospace and space technology stocks. The mix of fresh liquidity, staged share releases starting 6 August, and questions around profitability is creating cross currents that can affect related companies. This article walks through 3 stocks from our Aerospace & Space Technology screener that appear closely tied to this story so you can decide how, or if, they fit your watchlist.\nThe three stocks below are...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3051000-choice1-main-header/1585186568557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3051000-choice1-main-header/1585186568557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/ca/capital-goods/tsx-hps.a/hammond-power-solutions-shares/news/spacex-ipo-puts-aerospace-stocks-in-focus-with-hammond-power","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/ca/capital-goods/tsx-hps.a/hammond-power-solutions-shares/news/spacex-ipo-puts-aerospace-stocks-in-focus-with-hammond-power","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MARS","FRHC","SNK","BK4084","UFO","SPCH","KCE","LU2290526834.HKD","LOFF","LU1861559042.SGD","LU2360107168.USD","SPAX","BK4089","XOVR","DXYZ","REDS","SPCM","BK4234","SPAL","SSPC","BK4127","SPCQ","AVP","LU1861215975.USD","WARP","WSPC","SPCU","IPOS","SPCG","LU1861558580.USD","SPCX","ORBX","LU1861220033.SGD","BK4615","PW","SPCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657579696","title":"Avon Technologies (AVON) Gets a Buy from Peel Hunt","url":"https://stock-news.laohu8.com/highlight/detail?id=2657579696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657579696?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:06","pubTimestamp":1785963995,"startTime":"0","endTime":"0","summary":"Peel Hunt analyst reiterated a Buy rating on Avon Technologies today and set a price target of p2,250.00. In a report released today, Jefferies als...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/avon-technologies-avon-gets-a-buy-from-peel-hunt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/avon-technologies-avon-gets-a-buy-from-peel-hunt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657859567","title":"Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2657859567","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657859567?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873660,"startTime":"0","endTime":"0","summary":"BOSTON, Aug.  04, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338772/0/en/Rhythm-Pharmaceuticals-Announces-Participation-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","AVP","EC","BK4201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558369","title":"Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558369","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558369?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:55","pubTimestamp":1785840900,"startTime":"0","endTime":"0","summary":"-- -11.6% mean reduction in BMI from baseline at Week 16 (n=7) -- -- BMI reductions consistent with setmelanotide and bivamelagon -- -- Management to host conference call to discuss second quarter 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338126/0/en/Rhythm-Pharmaceuticals-Announces-Preliminary-Data-from-Phase-2-Trial-that-Showed-RM-718-Demonstrated-Positive-Efficacy-Signal-in-Acquired-Hypothalamic-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","BK4201","VUS","AVP","EC","RM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927705","title":"Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927705","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927705?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635200,"startTime":"0","endTime":"0","summary":"BOSTON, July  21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330408/0/en/Rhythm-Pharmaceuticals-to-Report-Second-Quarter-2026-Financial-Results-on-Tuesday-August-4-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","EC","BK4201","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155253950","title":"Provincial Disciplinary Authorities Announce Investigation into Li Yafang","url":"https://stock-news.laohu8.com/highlight/detail?id=1155253950","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155253950?lang=en_us&edition=fundamental","pubTime":"2026-07-11 18:41","pubTimestamp":1783766471,"startTime":"0","endTime":"0","summary":"The head of the Platform and Institution Department at the Jiangsu Provincial Department of Science and Technology, Li Yafang, is suspected of serious violations of discipline and law. She is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650919584","title":"Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2650919584","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650919584?lang=en_us&edition=fundamental","pubTime":"2026-07-09 05:07","pubTimestamp":1783544820,"startTime":"0","endTime":"0","summary":"BOSTON, July  08, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324480/0/en/Rhythm-Pharmaceuticals-Announces-The-New-England-Journal-of-Medicine-Publication-of-Phase-3-TRANSCEND-Trial-Results-in-Acquired-Hypothalamic-Obesity.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","BK4157","BMI","BK4087","CHMP","EMA","AVP","BK4201","EC","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649492686","title":"Avon Technologies: Analyst Maintains Buy Rating as New NATO Contract Strengthens Order Book and Medium-Term Revenue Visibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2649492686","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649492686?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:05","pubTimestamp":1783321516,"startTime":"0","endTime":"0","summary":"Andrew Douglas, an analyst from Jefferies, reiterated the Buy rating on Avon Technologies. The associated price target is p2,390.00. Andrew Douglas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avon-technologies-analyst-maintains-buy-rating-as-new-nato-contract-strengthens-order-book-and-medium-term-revenue-visibility-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avon-technologies-analyst-maintains-buy-rating-as-new-nato-contract-strengthens-order-book-and-medium-term-revenue-visibility-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646358145","title":"Andrew Douglas Reiterates Buy on Avon Technologies, Keeps $2390 Price Target After New U.S. Army Helmet Orders","url":"https://stock-news.laohu8.com/highlight/detail?id=2646358145","media":"TIPRANKS","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646358145?lang=en_us&edition=fundamental","pubTime":"2026-06-26 16:45","pubTimestamp":1782463540,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew Douglas from Jefferies reiterated a Buy rating on Avon Technologies, with a price target of p2,390.00. Andrew Do...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/andrew-douglas-reiterates-buy-on-avon-technologies-keeps-2390-price-target-after-new-u-s-army-helmet-orders-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/andrew-douglas-reiterates-buy-on-avon-technologies-keeps-2390-price-target-after-new-u-s-army-helmet-orders-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646331868","title":"Avon Technologies Secures Over $40 Million in U.S. Army Helmet Orders","url":"https://stock-news.laohu8.com/highlight/detail?id=2646331868","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646331868?lang=en_us&edition=fundamental","pubTime":"2026-06-26 14:17","pubTimestamp":1782454631,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) has shared an update. Avon Technologies, a defence-focused supplier of protective equipment for military and law e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-secures-over-40-million-in-u-s-army-helmet-orders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-secures-over-40-million-in-u-s-army-helmet-orders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ITA","AVP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643785500","title":"Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643785500","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643785500?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:01","pubTimestamp":1781553660,"startTime":"0","endTime":"0","summary":"-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO at 2.5 years --  -- Bivamelagon therapy achieved progressive reductions in BMI a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3312120/0/en/Rhythm-Pharmaceuticals-Announces-Multiple-New-Data-Presentations-from-MC4R-Agonists-in-Acquired-Hypothalamic-Obesity-HO-Bardet-Biedl-Syndrome-BBS-and-Prader-Willi-Syndrome-PWS-at-E.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENDO","PWS","EC","BK4183","BK4201","AVP","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643185082","title":"Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2643185082","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643185082?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:01","pubTimestamp":1781294460,"startTime":"0","endTime":"0","summary":"BOSTON, June  12, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/12/3311304/0/en/Rhythm-Pharmaceuticals-to-Announce-Interim-Six-Month-Phase-2-Results-Evaluating-Setmelanotide-in-Patients-with-Prader-Willi-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VUS","BK4201","PWS","AVP","EC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641648236","title":"Avon Technologies Executives Buy Shares Under All-Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2641648236","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641648236?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:46","pubTimestamp":1780922819,"startTime":"0","endTime":"0","summary":"Avon Technologies ( ($GB:AVON) ) just unveiled an update. Avon Technologies plc disclosed that its chief executive officer, Jos Sclater, and chief ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-buy-shares-under-all-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-executives-buy-shares-under-all-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639862225","title":"Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639862225","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639862225?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056000,"startTime":"0","endTime":"0","summary":"BOSTON, May  29, 2026  (GLOBE NEWSWIRE) --  Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/29/3303535/0/en/Rhythm-Pharmaceuticals-Announces-Seven-Abstracts-Accepted-for-Presentation-at-ENDO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ENDO","AVP","BK4201","EC","PWS","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698175","title":"Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698175?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"BOSTON, May  28, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302763/0/en/Rhythm-Pharmaceuticals-Announces-Publication-of-New-Bardet-Biedl-Syndrome-Diagnostic-Algorithm-in-the-American-Journal-of-Medical-Genetics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ENDO","AVP","BK4117","VUS","BK4107","BK4201","EC","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638514825","title":"Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2638514825","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638514825?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:00","pubTimestamp":1779796800,"startTime":"0","endTime":"0","summary":"BOSTON, May  26, 2026  (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ra","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/26/3300998/0/en/Rhythm-Pharmaceuticals-Announces-Participation-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP","EC","BK4201","VUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636158268","title":"Avon Technologies Delivers Profits Surge In Latest Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2636158268","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636158268?lang=en_us&edition=fundamental","pubTime":"2026-05-20 14:15","pubTimestamp":1779257737,"startTime":"0","endTime":"0","summary":"Avon Technologies plc (($GB:AVON)) has held its Q2 earnings call. Read on for the main highlights of the call. Avon Technologies’ latest earnings c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-delivers-profits-surge-in-latest-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-delivers-profits-surge-in-latest-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143970695","title":"Avon Technologies Reports Strong First-Half Performance with EPS of 56 Cents","url":"https://stock-news.laohu8.com/highlight/detail?id=1143970695","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143970695?lang=en_us&edition=fundamental","pubTime":"2026-05-14 03:22","pubTimestamp":1778700163,"startTime":"0","endTime":"0","summary":"UK-based military protective equipment manufacturer Avon Technologies Plc announced its financial results for the first half of fiscal year 2026 on Wednesday, reporting non-GAAP earnings per share of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635496205","title":"Avon Technologies: Buy Rating Reiterated on Strong 1H26 Performance and Outlook; $2,330 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2635496205","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635496205?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:15","pubTimestamp":1778656522,"startTime":"0","endTime":"0","summary":"Analyst Andrew Douglas from Jefferies maintained a Buy rating on Avon Technologies and keeping the price target at p2,330.00. Andrew Douglas has gi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-strong-1h26-performance-and-outlook-2330-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/avon-technologies-buy-rating-reiterated-on-strong-1h26-performance-and-outlook-2330-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635220837","title":"Avon Technologies Beats Profit Targets Early as Defence Demand Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=2635220837","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635220837?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:31","pubTimestamp":1778653901,"startTime":"0","endTime":"0","summary":"An announcement from Avon Technologies ( ($GB:AVON) ) is now available. Avon Technologies reported a strong first half to fiscal 2026, with revenue...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avon-technologies-beats-profit-targets-early-as-defence-demand-surges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avon-technologies-beats-profit-targets-early-as-defence-demand-surges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}]}}